[Thromboembolic complications following total hip prosthesis. Study of 478 cases of relative efficacy of 3 preventive methods].
D000925:Anticoagulants / Q000627:therapeutic use*; D001241:Aspirin / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003911:Dextrans / Q000627:therapeutic use; D004341:Drug Evaluation; D004359:Drug Therapy, Combination; D005260:Female; D006400:Hematocrit; D006621:Hip Joint / Q000601:surgery*; D006801:Humans; D007595:Joint Prosthesis; D008297:Male; D010003:Osteoarthritis / Q000601:surgery*; D011183:Postoperative Complications; D011655:Pulmonary Embolism / Q000209:etiology; D012204:Rh-Hr Blood-Group System; D013923:Thromboembolism / Q000188:drug therapy / Q000209:etiology* / Q000517:prevention & control; D013924:Thrombophlebitis / Q000517:prevention & control; D014859:Warfarin / Q000627:therapeutic use
D000925:Anticoagulants; D003911:Dextrans; D012204:Rh-Hr Blood-Group System; D014859:Warfarin; D001241:Aspirin
Complications thrombo-emboliques après prothèse totale de hanche. Etude sur 478 cas de l'efficacité relative de trois méthodes préventives